320 related articles for article (PubMed ID: 18653484)
1. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.
Raynauld JP; Martel-Pelletier J; Bias P; Laufer S; Haraoui B; Choquette D; Beaulieu AD; Abram F; Dorais M; Vignon E; Pelletier JP;
Ann Rheum Dis; 2009 Jun; 68(6):938-47. PubMed ID: 18653484
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis.
Raynauld JP; Martel-Pelletier J; Abram F; Dorais M; Haraoui B; Choquette D; Bias P; Emmert KH; Laufer S; Pelletier JP
Arthritis Res Ther; 2008; 10(6):R129. PubMed ID: 18986534
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI.
Wildi LM; Raynauld JP; Martel-Pelletier J; Abram F; Dorais M; Pelletier JP
Ann Rheum Dis; 2010 Dec; 69(12):2118-24. PubMed ID: 20610445
[TBL] [Abstract][Full Text] [Related]
4. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.
Raynauld JP; Martel-Pelletier J; Haraoui B; Choquette D; Dorais M; Wildi LM; Abram F; Pelletier JP;
Ann Rheum Dis; 2011 Aug; 70(8):1382-8. PubMed ID: 21551506
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.
Kahan A; Uebelhart D; De Vathaire F; Delmas PD; Reginster JY
Arthritis Rheum; 2009 Feb; 60(2):524-33. PubMed ID: 19180484
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.
Pelletier JP; Raynauld JP; Berthiaume MJ; Abram F; Choquette D; Haraoui B; Beary JF; Cline GA; Meyer JM; Martel-Pelletier J
Arthritis Res Ther; 2007; 9(4):R74. PubMed ID: 17672891
[TBL] [Abstract][Full Text] [Related]
7. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort.
Roubille C; Martel-Pelletier J; Abram F; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Semin Arthritis Rheum; 2015 Dec; 45(3):257-67. PubMed ID: 26094904
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.
Pelletier JP; Raynauld JP; Beaulieu AD; Bessette L; Morin F; de Brum-Fernandes AJ; Delorme P; Dorais M; Paiement P; Abram F; Martel-Pelletier J
Arthritis Res Ther; 2016 Nov; 18(1):256. PubMed ID: 27809891
[TBL] [Abstract][Full Text] [Related]
9. Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss views.
Vignon E; Piperno M; Le Graverand MP; Mazzuca SA; Brandt KD; Mathieu P; Favret H; Vignon M; Merle-Vincent F; Conrozier T
Arthritis Rheum; 2003 Feb; 48(2):378-84. PubMed ID: 12571846
[TBL] [Abstract][Full Text] [Related]
10. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.
Martel-Pelletier J; Roubille C; Abram F; Hochberg MC; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Ann Rheum Dis; 2015 Mar; 74(3):547-56. PubMed ID: 24336337
[TBL] [Abstract][Full Text] [Related]
11. Comparison of conventional standing knee radiographs and magnetic resonance imaging in assessing progression of tibiofemoral joint osteoarthritis.
Cicuttini F; Hankin J; Jones G; Wluka A
Osteoarthritis Cartilage; 2005 Aug; 13(8):722-7. PubMed ID: 15922634
[TBL] [Abstract][Full Text] [Related]
12. Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.
Zhai G; Pelletier JP; Liu M; Randell EW; Rahman P; Martel-Pelletier J
Arthritis Res Ther; 2019 Nov; 21(1):224. PubMed ID: 31694709
[TBL] [Abstract][Full Text] [Related]
13. Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography.
Le Graverand MP; Buck RJ; Wyman BT; Vignon E; Mazzuca SA; Brandt KD; Piperno M; Charles HC; Hudelmaier M; Hunter DJ; Jackson C; Kraus VB; Link TM; Majumdar S; Prasad PV; Schnitzer TJ; Vaz A; Wirth W; Eckstein F
Ann Rheum Dis; 2010 Jan; 69(1):155-62. PubMed ID: 19103634
[TBL] [Abstract][Full Text] [Related]
14. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.
Raynauld JP; Martel-Pelletier J; Berthiaume MJ; Beaudoin G; Choquette D; Haraoui B; Tannenbaum H; Meyer JM; Beary JF; Cline GA; Pelletier JP
Arthritis Res Ther; 2006; 8(1):R21. PubMed ID: 16507119
[TBL] [Abstract][Full Text] [Related]
15. Separation of healthy and early osteoarthritis by automatic quantification of cartilage homogeneity.
Qazi AA; Folkesson J; Pettersen PC; Karsdal MA; Christiansen C; Dam EB
Osteoarthritis Cartilage; 2007 Oct; 15(10):1199-206. PubMed ID: 17493841
[TBL] [Abstract][Full Text] [Related]
16. Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.
Martel-Pelletier J; Raynauld JP; Mineau F; Abram F; Paiement P; Delorme P; Pelletier JP
Arthritis Res Ther; 2017 Jul; 19(1):169. PubMed ID: 28728606
[TBL] [Abstract][Full Text] [Related]
17. Relation of regional articular cartilage morphometry and meniscal position by MRI to joint space width in knee radiographs.
Hunter DJ; Buck R; Vignon E; Eckstein F; Brandt K; Mazzuca SA; Wyman BT; Otterness I; Hellio Le Graverand MP
Osteoarthritis Cartilage; 2009 Sep; 17(9):1170-6. PubMed ID: 19401243
[TBL] [Abstract][Full Text] [Related]
18. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography.
Hellio Le Graverand MP; Clemmer RS; Brunell RM; Hayes CW; Miller CG; Vignon E
Semin Arthritis Rheum; 2013 Aug; 43(1):1-8. PubMed ID: 23290692
[TBL] [Abstract][Full Text] [Related]
19. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes.
Raynauld JP; Martel-Pelletier J; Berthiaume MJ; Labonté F; Beaudoin G; de Guise JA; Bloch DA; Choquette D; Haraoui B; Altman RD; Hochberg MC; Meyer JM; Cline GA; Pelletier JP
Arthritis Rheum; 2004 Feb; 50(2):476-87. PubMed ID: 14872490
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.
Pelletier JP; Boileau C; Boily M; Brunet J; Mineau F; Geng C; Reboul P; Laufer S; Lajeunesse D; Martel-Pelletier J
Arthritis Res Ther; 2005; 7(5):R1091-102. PubMed ID: 16207326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
